Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

Esther Redder; Nils Kirschnick; Stefanie Bobe; René Hägerling; Nils Rouven Hansmeier; Friedemann Kiefer

doi:10.1371/journal.pone.0249256

. 2021 Sep 20;16(9):e0249256. doi: 10.1371/journal.pone.0249256

Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

Esther Redder ^1,^2,^#, Nils Kirschnick ^1,^2,^#, Stefanie Bobe ^1,², René Hägerling ^2,^¤, Nils Rouven Hansmeier ^2,^¤, Friedemann Kiefer ^1,^2,^*

Editor: Stefan Liebner³

PMCID: PMC8452004 PMID: 34543279

Abstract

Lymphatic vessels are indispensable for tissue fluid homeostasis, transport of solutes and dietary lipids and immune cell trafficking. In contrast to blood vessels, which are easily visible by their erythrocyte cargo, lymphatic vessels are not readily detected in the tissue context. Their invisibility interferes with the analysis of the three-dimensional lymph vessel structure in large tissue volumes and hampers dynamic intravital studies on lymphatic function and pathofunction. An approach to overcome these limitations are mouse models, which express transgenic fluorescent proteins under the control of tissue-specific promotor elements. We introduce here the BAC-transgenic mouse reporter strain Vegfr3-tdTomato that expresses a membrane-tagged version of tdTomato under control of Flt4 regulatory elements. Vegfr3-tdTomato mice inherited the reporter in a mendelian fashion and showed selective and stable fluorescence in the lymphatic vessels of multiple organs tested, including lung, kidney, heart, diaphragm, intestine, mesentery, liver and dermis. In this model, tdTomato expression was sufficient for direct visualisation of lymphatic vessels by epifluorescence microscopy. Furthermore, lymph vessels were readily visualized using a number of microscopic modalities including confocal laser scanning, light sheet fluorescence and two-photon microscopy. Due to the early onset of VEGFR-3 expression in venous embryonic vessels and the short maturation time of tdTomato, this reporter offers an interesting alternative to Prox1-promoter driven lymphatic reporter mice for instance to study the developmental differentiation of venous to lymphatic endothelial cells.

Introduction

The lymphatic vessel system consists of a blind-ending network of capillaries (capLV) that take up interstitial fluid, solutes, dietary lipids and cells, which together constitute the lymph. Subsequently, lymph is routed via collecting lymphatic vessels (colLV) to connections with subclavian veins where it enters the blood stream. Oak-leaf shaped lymphatic endothelial cells (LECs), with specialized junctions that form discontinuous, “button-like” cell-cell contacts facilitate fluid uptake into capLVs [1]. Transport of lymph within the fluid-tight colLVs is facilitated by intraluminal valves and coordinated contraction of smooth muscle cells [1–5]. Besides its essential function for the maintenance of tissue homeostasis, the lymphatic system is also indispensable for immune cell trafficking and dietary fat absorption, which also ensures the uptake of fat-soluble vitamins from the intestine [3, 6]. During embryonic development the first LECs differentiate within the cardinal and superficial veins [7, 8], while non-venous origins of LECs have been identified to contribute to lymph vessels (LV) in multiple vascular beds [9–11]. Development and maintenance of LVs are dependent on the key regulator VEGF-C, which signals via its receptor VEGFR-3 [10, 12–19]. The expression of VEGFR-3 in the mouse starts early during embryonic development in developing blood vessels but becomes largely restricted to the lymphatic vessels after midgestation [20]. Both, homozygous loss of either ligand or receptor result in prenatal death, deficient lymphatic sprouting and general vascular defects [14, 21].

In recent years, many factors have been identified that contribute to and are essential for LV development and maintenance during adulthood. Fluorescence-based visualization of vascular networks has profoundly contributed to this advancement. So far, different transgenic mouse lines have been described, which are suitable for fluorescent detection of LVs. Several lines are based on the expression of fluorescent proteins, e.g. GFP [22–24], mOrange2 [25] or tdTomato [26–28], under the control of the Prox1 promoter. Furthermore, transgenic models using Vegfr3 transcriptional elements to express fluorescent reporters are also reported [29–32]. However, the investigation and dynamic visualization of complex lymph vessel beds in specific organs are still underrepresented. A reason for this is the requirement for lymphatic reporters that encode bright fluorescent proteins as well as limited availability of wholemount immunostaining protocols with sufficient penetration depth, suited for the visualization of the LV beds in large volumes. Furthermore, access to complex imaging and tissue clearing techniques that preserve reporter protein fluorescence and allow for deep, three-dimensional (3D) volume imaging are still limited to a relatively small number of laboratories.

In response to this obvious demand, we decided to generate a novel lymphatic reporter mouse model that is suitable for multiple imaging modalities including confocal laser scanning (CLSM), light sheet fluorescence (LSFM) and two-photon laser scanning (2P-LSM) microscopy. This wide spectrum of microscopic modalities allows high resolution as well as dynamic or 3D visualization of the lymphatic network in large tissue volumes. Based on its relative brightness, excitation and emission spectra and fast maturation time, we expressed the tandem-dimer derivate of RFP, tdTomato [33] under transcriptional control of the Vegfr3 promotor to label LECs in mice. Here, we show efficient labelling of LVs by the Vegfr3-tdTomato transgene in various murine tissues and demonstrate co-localization with immunostained VEGFR-3 and various identifying lymphatic markers. This confirms LEC-specific expression and makes this mouse line a valuable tool for LV imaging, as well as LEC FACS isolation. Moreover, the reporter can be useful for dynamic intravital microscopy of lymphatics. Tissue clearing and co-staining techniques in combination with LSFM allow for visualization of complex three-dimensional structures in so far under explored tissues.

Results

Generation of a Vegfr3-tdTomato transgenic mouse line

The VEGF-C / VEGFR-3 pathway is known to exhibit strong dose dependency. We therefore generated a transgenic model, in which a tdTomato-CAAX-pA cDNA was inserted into BAC clone RP23-58E13 harbouring the Flt4 transgene by Red/ET recombineering. The expression cassette utilized the VEGFR-3 initiating ATG located in the first exon and replaced the remainder of the exon, practically putting tdTomato under the control of Flt4 promotor elements (Fig 1A). Linearized BAC DNA of 214.464 kb size was used for pronuclear injection and yielded 74 mice, of which 14 had integrated the transgene, as verified by genomic PCR analysis (Fig 1B). To probe for tdTomato expression, the founders were mated to wildtype C56Bl/6 mice and we isolated and cultured endothelial cells from the dermis using anti-CD31-coated magnetic beads. The resulting primary cell cultures were comprised of a mixture of endothelial cells (ECs) of blood and lymphatic origin. The observed patches of tdTomato expression were expected, since only LECs should express consistently high levels of the Vegfr3-driven tdTomato reporter (Fig 1C). In total we identified three individuals exhibiting a particularly bright tdTomato fluorescence i.e. expression.

Fig 1 — A) Schematic representation of the modified genomic region around the initiating ATG of the mouse *Flt4* gene in the BAC *Vegfr3*-tdTomato used for pronuclear injection. A cDNA expression cassette encoding the fluorescent protein tdTomato C-terminally fused to a CAAX-box for membrane-anchoring followed by a SV40-polyadenylation signal (pA) for positive selection was inserted into the BAC clone RP23-58E13 such that the initiating ATG of the *Vegfr3* was now usurped by tdTomato. For Red/ET recombineering, 3’ and 5’ *Vegfr3* homology regions derived from the genomic sequences preceding the initiating ATG and following Exon1 were added on both ends of the targeting cassette. Primers for PCR identification of recombinant clones and transgenic animals are indicated. B) Verification of the recombined BAC and successful transgenesis by PCR. The heterozygously transmitted allele is indicated by +/T. C) Differential interference contrast (DIC) and fluorescence images of primary dermal lymphatic endothelial cells (pdLECs) from *Vegfr3*-tdTomato transgenic mice following magnetic bead-based isolation and enrichment. Images were captured in passage 1. Magnetic beads appear a round black spheres. Scale bars = 50 μm.

For the subsequent establishment of a reporter mouse line, stably inheriting the transgene, we elected the founder displaying the highest relative brightness of tdTomato fluorescence. The female founder transmitted the transgene with Mendelian distribution and in all subsequent generations, Vegfr3-tdTomato mice were fertile and appeared healthy, without detectable abnormalities.

The tdTomato fluorescence is associated with the lymphatic vessel network and co-localizes with VEGFR-3 protein expression

To test the expression of tdTomato in different lymphatic vessel beds, we analysed freshly isolated and unfixed organs from adult transgenic mice (Fig 2A–2F, 2I and 2J) and pups at postnatal day 5 (P5, Fig 2G, 2H and 2K–2T) using a fluorescence stereomicroscope and an inverted fluorescence microscope. Lymph vessels were easily identifiable due to the characteristic pattern of tdTomato expression in all analysed tissues including the diaphragm, lung, ear skin, intestinal mucosa, mesentery, mesenteric LN and heart (Fig 2).

Fig 2 — Tissues prepared from adult mice (A-F, I-J) and pups at postnatal day 5 (G-H, K-T) were analysed for lymphatic expression of the *Vegfr3*-tdTomato transgene in a fluorescence stereo dissection microscope (A-L) and an inverted fluorescence microscope (M-T). Distinct lymphatic networks were detected in various adult tissues including the diaphragm (A-C), lung (D), ear dermis (E), intestinal mucosa (F), and heart (I-J) as well as postnatal tissues including the mesentery (G-H, O-P, S-T), mesenteric lymph nodes (G, O-P), heart (K-L) and diaphragm (M-N, Q-R). White asterisk denotes the position of the LN. The white and black boxed areas are magnified in the indicated panels. Scale bars = 400 μm (M-P) and 200 μm (Q-T).

We further investigated PFA fixed, wholemount immunostained tissues by CLSM to confirm co-expression of tdTomato with VEGFR-3 and the established lymphatic marker PROX1. Since fixation reduces the brightness of fluorescent proteins, we used an anti-RFP staining to visualize the tdTomato signal. In this analysis, all tdTomato-positive LVs were also found to express the VEGFR-3 protein (Figs 3A–3C and 4A–4C), verifying the lymphatic identity of the tdTomato-positive vessels and demonstrating faithful Flt4 promoter-driven expression of the transgene. As expected, the tdTomato reporter was absent from CD31-positive, but VEGFR-3-negative blood vessels (Figs 3A, 3B and 4A–4C). While in adult mice VEGFR-3 is largely restricted to LVs, selected blood endothelial cells (BECs) have been shown to express VEGFR-3. These include tip cells of the postnatal retina [18] as well as liver sinusoidal endothelial cells [34] and we therefore investigated Vegfr3-tdTomato expression in these tissues (S1 Fig). In the angiogenic, sprouting front of the retina, tdTomato expression was absent although VEGFR-3 protein expression was confirmed by immunofluorescence staining (S1A Fig). In addition, immunostained vibratome sections of the adult liver showed prominent expression of tdTomato in LVs around the portal veins, while only a weak signal was detectable in VEGFR-3-positive sinusoids (S1B Fig).

Fig 3 — **A-C)** Maximum intensity projection (MIP) of representative confocal tile-scans from wholemount immunostained ear skin (A) and diaphragm (B-C) of adult *Vegfr3*-tdTomato transgenic mice. Stained antigens are indicated above each panel. The white boxed area in (A) is magnified in (B). Scale bars = 200μm (A), 100μm (A, magnification), 50μm (B,C).

Fig 4 — **A-F)** Wholemount immunostained preparations of mesenteries from *Vegfr3*-tdTomato transgenic pups at P5. Shown are MIPs of multi-tile z-stacks stained for the antigens depicted in colour above each panel. Magnifications of the areas boxed in white dashed lines in (A) and (D) are shown in the indicated panels (B,C and E,F). RFP staining identified transgene expression in lymphatic vessels. Yellow arrow heads indicate formation of semilunar valves. Scale bars = 1000 μm (A, B), 200 μm (B-C, E-F).

Taken together these data show that in the newly generated Vegfr3-tdTomato mouse Tomato expression was readily detectable in LECs, in which it faithfully recapitulated VEGFR-3 expression.

The fluorescent reporter tdTomato is expressed in both capillary and collecting lymphatic vessels of various tissues

Next, we wondered if in Vegfr3-tdTomato mice the fluorescent reporter was expressed in capLV and colLV, which both express VEGFR-3. In contrast to VEGFR-3, the hyaluronan receptor LYVE1 specifically marks the oak-leaf shaped LECs of capLVs. In the dermal LVs of the ear and the LVs of the diaphragm, blind-ending LYVE1-positive capLVs are particularly prominent. In immunostained wholemount preparations of both tissues, we readily noted co-localization of tdTomato and LYVE1 expression in capLVs during CLSM analysis (Fig 3A–3C). Despite the presence in all capLVs and colLVs vessels, we noted some heterogeneity in the tdTomato staining intensity between individual LECs within a vessel. To follow this observation further and to probe for a possible expression mosaicism, we analysed isolated cells from the lung of Vegfr3-tdTomato transgenic mice by flow cytometry (S2 Fig). Indeed, when we gated on LECs, characterized by CD31 and Podoplanin (PDPN) expression, we found that only 2.83% of the double positive LECs of the lung showed tdTomato expression (S2E Fig). This value improved when we exclusively considered the PDPN^high population, where 40% expressed tdTomato (S2F Fig).

Postnatal mesenteric LVs are prominently comprised of colLVs, which do not express LYVE1 but retain VEGFR-3, PROX1 and CD31 expression. Mesenteric colLVs strongly expressed tdTomato, which co-localized with the before-mentioned lymphatic markers (Fig 4). We identified newly forming intraluminal valves based on high PROX1 expression in the nascent semilunar leaflets (Fig 4E and 4F, yellow arrow heads). Collectively, these data confirm the lymphatic identity of tdTomato positive vessel structures and demonstrate consistent tdTomato expression in both capLVs and colLVs at different developmental stages.

The Vegfr3-tdTomato mouse is a tool for two-photon microscopy

Presently, CLSM is probably the most widely used microscope modality in biomedical research, due to it low penetration depth and high energy transfer into tissue it is widely used for post mortem analysis of immunostained specimen. For intravital imaging or the analysis of deep tissue layers, 2P-LSM has become an established, yet not widely used technology, which may partly be due to relatively high costs, technological complexity and significantly lower optical resolution compared to CLSM. Significant advantages of 2P-LSM result from the near infrared excitation light used in this modality and include relatively deep tissue penetration ranging from few hundred micrometres to nearly one millimetre depending on the tissue investigated and the lower phototoxicity as compared to visible light [35].

Therefore, we were interested to demonstrate the suitability of our Vegfr3-tdTomato reporter mouse line for intravital or deep tissue imaging using 2P-LSM. As shown in Fig 5A, tdTomato is optimally excited at a wavelength of 1100 nm [25, 36]. Ex vivo 2P-LSM analysis of skin from Vegfr3-tdTomato foetuses (E14.5), in which the blood vessels had been contrasted with anti PECAM-1 antibodies revealed the tdTomato-expressing lymphatic vessel plexus and the stained blood vasculature up to a depth of 200 μm (Fig 5B). Also, in adult tissues, like the diaphragm visualization of tdTomato expressing LECs was readily possible. The label-free second-harmonic generation signals originating from the muscle myosin of the skeletal muscle provided anatomical positioning (Fig 5C). In the somewhat denser adult diaphragm, imaging up to a tissue depth of around 150 μm was possible. Taken together these results show the applicability of our Vegfr3-tdTomato reporter mouse for deep tissue imaging using 2P-LSM.

Fig 5 — A) Spectral characteristics of the tdTomato fluorophore [33, 36]. 1P, single photon excitation spectrum, 2P, two photon excitation spectrum, em, emission spectrum. B) Expression of *Vegfr3*-tdTomato reporter construct in the superficial lymphatic vasculature of foetal skin (E14.5) imaged by 2P-LSM. The blood vasculature was contrasted with Alexa Fluor^™ 647-labelled anti PECAM1 antibodies. C) Confirmation of *Vegfr-3* promoter driven expression of the fluorescent reporter protein tdTomato in lymphatic vessels of the adult thoracic diaphragm. Due to its non-centrosymmetric biomolecular organization skeletal muscle of the diaphragm generates intense second harmonic generation (SHG) signals, that are visualized as green, repetitively striated signal. Shown are MIPs of 200 μm (B) and 150 μm (C) z-stacks. Scale bars = 50 μm.

The Vegfr3-tdTomato reporter model is also suitable for optical clearing and 3-dimensional visualization of lymphatic vessel networks by light-sheet fluorescence microscopy

Imaging of large tissue volumes (up to several cm³) requires the use of specialized modalities in particular light sheet fluorescence microscopes (LSFM) are well suited for this task. LSFM requires optical clearing to reduce light scattering. Because most clearing procedures reduce the brightness of reporter proteins, the remaining fluorescence is typically not bright enough for imaging of large tissue volumes even cleared tissue samples. We tested Vegfr3-tdTomato reporter tissues using different optical clearing protocols to probe the suitability of this strain for large volume imaging. Organic solvent-based clearing protocols offer excellent tissue transparency but quench protein fluorescence virtually completely [37]. Therefore, we used wholemount immunostaining with an RFP antibody to counterstain all tissue specimen derived from a Vegfr3-tdTomato pup at P5 that were subsequently cleared following the BABB protocol (Fig 6). 3D-volume rendering of image stacks was performed using the open source visualization software package Voreen [38, 39]. In the lung a highly branched lymphatic network was observed lancing both lobes to the level of the terminal bronchioles (Fig 6A–6C). In addition, prominent lymphatic vessels surrounded the trachea and primary bronchi (S1 Video). The organ volume was delineated via tissue autofluorescence in the green channel (Fig 6A–6C). A kidney explant allowed visualization of the developing renal lymphatic vasculature. Lymph vessels, that start to pervade the renal cortex, follow interlobar blood vessels towards the renal pelvis, where they run into large hilar collecting lymph vessels located adjacent the major renal arteries and veins (Fig 6D and 6E, S2 Video). Finally, we visualized the developing LVs in the mouse heart, which as previously described [40]. LVs are located particularly in the epicardium but hardly invade into the myocardium as described for larger mammals. In addition, LVs form a dense network around the root of the aorta (Fig 6F+6G, S3 Video).

Fig 6 — **A-E)** Volume reconstruction of lymphatic vessels in the lung (A-C) and kidney (D+E) of *Vegfr3*-tdTomato reporter mice at P5. Immunostaining for RFP identified expression of the *Vegfr3*-tdTomato transgene. Endogenous tissue autofluorescence (AF) allowed contrasting of the overall organ volume. **F+G)** 3D visualization of cardiac lymphatic vessels by immunostaining for RFP indicating expression of the *Vegfr3*-tdTomato transgene. Blood vasculature was visualized by Alexa Fluor^™ 647-labelled anti PECAM1 antibodies. The yellow boxed areas are magnified in the indicated panels.

To overcome the limitations associated with wholemount immunostaining and to minimize the fluorescence loss of tdTomato due to tissue clearing as much as possible, we applied the hydrophilic tissue clearing protocol CUBIC (Fig 7) [41]. Here fluorescence of tdTomato was retained allowing the direct visualization of the lymphatic vasculature of the lung’s right lobe and the heart without need for counterstaining. Also in CUBIC-cleared tissue green autofluorescence was used to delineate organ outline and volume (Fig 7A and 7B). Collectively, these results show that large volume imaging of LVs in Vegfr3-tdTomato reporter mice was possible using organic solvent-based or hydrophilic tissue clearing methods. However, for organic solvent-based clearing wholemount immunostaining was mandatory to compensate the loss of protein fluorescence.

Fig 7 — **A+B)** 3D visualization of tdTomato positive lymphatic vessels in the lung (A) and heart (B) of *Vegfr3*-tdTomato reporter mice at P5. Tissue autofluorescence (AF) was used to contrast organ topography.

Discussion

We report the generation and characterization of a Vegfr3-tdTomato reporter mouse line for imaging the lymphatic vasculature by multiple modalities. Although not formally proven in this study, the Vegfr3-tdTomato line should also be suitable for combination of microscopic imaging with molecular or whole-body imaging in multi-modal approaches. The tdTomato reporter showed bright, homogenous and consistent red fluorescence in LECs of all LVs investigated in this study and was successfully applied in a wide range of microscope modalities, including fluorescence stereomicroscopy, CLSM, 2P-LSM and LSFM. Further, the reporter can be exploited for the isolation of LECs from tissues and can be combined with other fluorescent proteins for multi-colour analysis.

For generation of the transgenic line, we inserted a cDNA expression cassette encoding a membrane-tagged version of tdTomato into the BAC RP23-58E13 that harbours 214kB of mouse genomic sequence from chromosome 11 including the Flt4 coding and presumably most regulatory sequences. The expression cassette was inserted by Red/ET recombineering such that tdTomato utilizes the initiating ATG of the VEGFR-3 and the cDNA replaces the remainder of Exon1. We chose tdTomato because it is among the brightest red fluorescent proteins [33]. Consequently, we expected our reporter to allow deeper imaging compared to other available LEC-specific reporter lines [22, 23, 25–28, 31, 42]. Furthermore, in contrast to previously published GFP-based lymphatic reporters [29, 30, 32] the red-shifted excitation and emission spectrum of tdTomato should aid in avoiding abundant green tissue autofluorescence (Fig 5A). In addition, combination with other especially green fluorescent reporter mouse lines is possible to simultaneously visualize for example distinct vascular beds by crossbreeding with lines specifically labelling blood ECs [43–45].

Following pronuclear microinjection, analysis of the transgenic offspring indicated that tdTomato had been successfully subjected to transcriptional control of the Flt4 gene, hence restricting the expression to LECs but not BECs after the onset of embryonic LV formation. To establish the Vegfr3-tdTomato reporter mouse line, we bred the founder displaying the brightest and most uniform tdTomato-fluorescence in all analysed LV beds. The transgene genomic integration site tends to be of minor importance in BAC transgenesis, indeed locus-specific influences bear the danger to interfere with faithful control through the transgene promotor, which in our Vegfr3-tdTomato line appeared however to be maintained. A possible explanation for the superior tdTomato expression might be the integration of multiple copies, very likely in the same integration site, as we did not note segregation of transgenes in subsequent generations.

In all anatomical locations analysed, tdTomato expression was restricted to the lymphatic vasculature, while absent from blood vessels. Several proteins including PROX1, PDPN, VEGFR-3 and LYVE1 have in recent years been used as markers to identify or isolate LECs, however, none of these is exclusively expressed in LECs. LYVE1 expression in adult mice is besides inflammatory cells largely restricted to capLVs and hence not suitable for reporter expression [46]. Besides LECs, PROX1 is expressed in a wide range of non-endothelial cell types (e.g. hepatocytes [47], cardiomyocytes [48] or neural cells of the retina [49]), while PDPN displays an even wider expression pattern, including various types of fibroblasts, epithelial and hematopoietic cells [50]. An advantage of Vegfr3-driven reporter gene expression, is the more EC-restricted VEGFR-3 expression, which in adult mice in addition to LECs is limited to a small subset of BECs in the angiogenic front of the developing retina [18], sinusoidal endothelial cells of the liver [34] and BECs in tumors [51]. Interestingly, in our Vegfr3-tdTomato mouse, VEGFR-3-expressing was not detectable on retinal tip cells and only weakly on liver sinusoidal endothelial cells. A hierarchical network of LVs was detectable and co-localization with lymphatic-specific markers in capLVs and colLVs was retained in wholemount preparations. The Vegfr3-tdTomato transgene recapitulated largely the endogenous VEGFR-3 expression in LECs and the plasma membrane localization aided visualization of tubular LV structures and distinctly delineated the shape of single LECs. In our wholemount stained samples, we noted some heterogeneity of the tdTomato staining intensity, suggesting that marker expression was patchy. Flow cytometric verification indeed detected a substantial proportion of tdTomato-negative cells in the CD31, PDPN double positive population that was least in the CD31, PDPN^High cells. This, together with the absence or only sporadic marker expression in retinal tip cells and liver sinusoidal endothelial cells suggests that the Vegfr3-tdTomato mouse does not report weak VEGR-3 promotor activity, which nevertheless results in an unexpected even beneficial specificity for LVs. Reasons may reside in the lack of distant regulatory elements in the promotor-containing BAC used to generate this mouse model or in the inability of the chosen fluorescent protein to report minute expression levels. Given its high brightness and fast maturation time tdTomato was the protein of choice. Certainly following immunostaining, we were able to visualize all LVs that would be identifiable on the basis of the before mentioned marker proteins.

Since dehydration and lipid extraction during optical tissue clearing with organic solvents efficiently quenches protein-based fluorescence, we used wholemount immunostaining with an anti-RFP antibody to detect tdTomato expression, which allowed us to visualize deep LVs in large tissue volumes [52]. While providing bright signals with a high signal to noise ratio, wholemount immunostaining remains limited by potential inaccessibility of the tissue to antibody staining. To overcome this obstacle, we applied the CUBIC tissue clearing protocol, which is based on detergent-mediated lipid extraction in hyper-hydrated samples [41]. This protocol retained the tdTomato fluorescence in transgenic tissues to a degree where again three-dimensional visualization of deep LVs was possible. For the analysis of complex vascular structures in large tissue volumes LSFM followed by digital image reconstruction is the most suitable imaging modality, which allowed us to reconstruct the complexity of the lymphatic vasculature in whole organs with a level of details that has not been shown to this extend and quality earlier. Finally, tissue clearing is not possible when intravital imaging of tdTomato in live animals is attempted. We demonstrated the suitability of our reporter mouse by 2P-LSM on unfixed, freshly isolated samples, where the fluorescence of LV-associated tdTomato was readily detectable up to a depth of 300 μm at an excitation wavelength of 1100 nm.

Conclusion

The Vegfr3-tdTomato reporter mouse strain that we have described in this study showed reliable labelling of lymph vessels in all analysed tissues including the dermis, mesentery, lymph nodes, intestinal mucosa, diaphragm, heart, lung, liver and kidney.

The model is applicable to tissue clearing, the CUBIC protocol will preserve the endogenous fluorescence of tdTomato. The line was suitable for a wide range of different imaging techniques and it allowed us to visualize the, so far not reported, complex architecture of the deep lymphatic plexus in various organs. Moreover, our reporter opens a number of important applications in intravital microscopy as it is photostable and bright. It is therefore a useful and advantageous tool for future dynamic explorations of the lymphatic vasculature.

Material and methods

Generation of a Vegfr3-tdTomato reporter mouse

We have flanked a cDNA, coding for the membrane-tagged RFP-derivate tdTomato-CAAX followed by an ampicillin-resistance cassette for positive selection with homology regions of the murine Flt4 gene. Targeting vectors were sequenced to verify correct insertion of the DNA fragments. We used Red/ET recombineering in E. coli DH10B to generate a modified bacterial artificial chromosome (the BAC clone RP23-58E13, harbouring the Flt4 gene within 214kB of genomic sequence of mouse chromosome 11). The construct was designed such that the VEGFR-3 start codon became the tdTomato start codon. Linearized DNA was used for pronuclear injection into fertilized zygotes, which were implanted into pseudo-pregnant C57Bl/6 females. Transgenic founders were identified by genomic PCR analysis (PCR1: fwd 5’-GACAACAACATGGCCGTCA-3’, rev 5’-CTTGTACAGCTCGTCCATGC-3’ and PCR2: fwd 5’- GCTCTCACTCCCAGCCTAG-3’, rev 5’-ACTCTTTGATGACGGCCATGTT-3’) and were subsequently screened for Vegfr3 promotor-driven tdTomato expression by stereomicroscopy of the dermal lymphatic vascular plexus in ear skin biopsies. One of three founders was selected for line establishment, based on the brightness of tdTomato fluorescence.

Animal experiments

Mice were kept under conventional conditions in IVC-cages and ventilated racks at 22°C and 55% humidity with a light-dark cycle of 14:10 h. Transgenic Vegfr3-tdTomato mice were analysed at the age of postnatal day 5 (P5) to 21 weeks. Foetuses were analysed at developmental stage of E14.5. Embryonic staging was determined by the day of the vaginal plug (E 0.5). Wildtype littermate mice served as controls. In all experiment’s mice were sacrificed by cervical dislocation. All Procedures involving animals were carried out in strict accordance with the German animal protection legislation (Tierschutzgesetz und Tierschutzversuchstierverordnung). The protocol was approved (84–02.04.2016.A218) by the Committee on the Ethics of Animal Experiments of the Landersamt für Natur, Umwelt und Verbraucherschutz (LANUV).

Antibodies

The following antibodies were used: rabbit polyclonal anti-human PROX1 (ReliaTech, 102-PA30), goat polyclonal anti-human PROX1 (R&D Systems, AF2727), rat monoclonal anti-mouse PECAM-1 (clone 5D2.6 and clone 1G5.1 [53]), goat polyclonal anti-mouse LYVE1 (R&D Systems, AF2125), rat monoclonal anti-mouse LYVE1 (clone 223322, R&D Systems; MAB2125), goat polyclonal anti-mouse VEGFR-3 (R&D Systems, AF743), rabbit polyclonal anti-RFP (Rockland, 600-401-379), rat monoclonal anti-CD31 FITC (clone 390; Invitrogen, Cat# RM5201), Syrian Hamster anti-Podoplanin eFluor^®660 (clone 8.1.1; eBioscience, Cat# 50-5381-82) and Isolectin GS-IB4 Alexa Fluor^™ 647 conjugate (Invitrogen, Cat# I32450). Secondary Alexa-dye labelled antibodies were obtained from Life Technologies.

Isolation of murine lung cells for flow cytometric analysis

Cells were isolated from the lung of Vegfr3-tdTomato mice. Tissues were enzymatically digested in 1 mg/ml Collagenase A solution for 30 min at 37°C. Single cells were collected and stained for 30 min with dye-conjugated primary antibodies diluted in FACS buffer (3% fetal calf serum in PBS). After antibody staining, the cells were analyzed on a FACSAria IIIu cell sorter (BD Biosciences) using an 85 μm nozzle. Cells were gated based on FSC and SSC to exclude cellular debris and doublets and on DAPI exclusion for viability. Cells were gated on the basis of CD31 and PDPN double positivity and then analysed for tdTomato expression. Data analysis was done using FlowJo software (LLC).

Isolation and culture of dermal endothelial cells

Primary dermal endothelial cells (ECs) were isolated from the tail skin of transgenic mice as described previously [54]. In brief, tail skin fragments were digested with 5% dispase/PBS to remove the epidermis from the dermis. Dermal fragments were then transferred into 1 mg/mL Collagenase A solution to maintain a single cell suspension. Single cells were incubated with magnetic dynabeads (coated with sheep anti-rat IgG) coupled to anti-CD31 antibody (clone mec13-3). CD31-positive ECs of both lymph- and blood vessel origin were enriched by magnetic separation. For cultivation of lymphatic endothelial cells (LECs) preselected batches of ECGS (BT-203, Alfa Aesar) that favour the expansion and maintenance of lymphatic endothelium were used. LECs were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 20% FCS, 2 mM L-glutamine, 100 μg/mL penicillin/streptomycin, 1% sodium pyruvate, 0,1 mM non-essential amino acids, 20 μg/mL ECGS, 50 μg/mL Heparin, 50 μM β-mercaptoethanol and cultured on 0.4% gelatine coated petri dishes or multi-well plates at 37°C, 10% CO₂ and 95–100% humidity. Enriched LEC cultures in passage 1 were used for fluorescence imaging.

Wholemount staining of embryonic and adult tissues

Tissues were fixed in 4% PFA for 2 h and washed with PBS. Subsequently, samples were permeabilized in 0.5% Triton X-100 in PBS, blocked in PermBlock solution (3% BSA, 0.1% Tween-20 in PBS) and stained with the listed primary antibodies at 4°C. Following three washing steps with PBS-T (0.1% Tween-20), tissues were incubated in secondary antibodies labelled with Alexa-dyes and mounted with Mowiol.

Optical tissue clearing

Optical clearing was described previously [41]. Briefly, prior fluorescence light sheet imaging, postnatal wholemount stainings were embedded in 2% low-melting point agarose. For organic solvent-based clearing the samples were dehydrated in increasing concentrations of methanol (50%, 70%, 99.5%, 99.5% methanol (v/v), each step at least 1 hour) and then optically cleared in a benzyl alcohol:benzyl benzoate solution (BABB; ratio 1:2) for 4h.

For CUBIC-based tissue clearing samples were incubated in reagent-1A up to 4 days. while reagent-1A was replaced every 24 hours. Afterwards samples were washed several times in PBS and were then incubated reagent-2 until final transparency. Before Imaging the samples were immersed in silicon oil (Sigma, 175633) for at least 1 hour.

Microscopy

Widefield fluorescence microscopy

Imaging of murine tissue samples and LEC cultures was conducted on a Nikon Eclipse Ti2 inverted fluorescence microscope (Nikon, Japan) using a 10X Plan Fluor (NA 0.3, WD 15.20 mm) objective and appropriate emission filter sets for Cy3 (577/25 nm). The system is equipped with a SPECTRA X light engine^® (Lumencor, USA) for excitation.

Stereomicroscopy

Unfixed and unstained Vegfr3-tdTomato mice were analysed with a Leica Stereomicroscope MZ16F coupled to a digital camera (Hamamatsu C4742-95). Volocity software (Perkin Elmer) was used for image acquisition and processing.

Confocal laser scanning microscopy and image processing

Confocal images were captured using an LSM 880 confocal microscope (Carl Zeiss; 10x, NA = 0.45; 20x, NA = 0.8; 40x water, NA = 1.2; 63x oil, NA = 1.4). Microscopy data were recorded and processed with ZEN Pro software (Carl Zeiss). All confocal images represent maximum intensity projections of z-stacks of either single tile or multiple tile scan images. Mosaic tile-scans with 10% overlap between neighbouring z-stacks were stitched in ZEN software. Confocal single and multi-tile-scans were processed in Fiji [55]. If necessary, adjustments to brightness, contrast and intensity were equally accomplished for individual channels and compared data sets.

Light sheet fluorescence microscopy and 3D-image processing

Optically cleared samples were imaged on a LaVision BioTec Ultramicroscope II (LaVision BioTec, Bielefeld, Germany) equipped with an Olympus MVX10 Zoom Microscope Body (Olympus, Tokyo, Japan) allowing an optical magnification range from 1.26x to 12.6x and an NA of 0.5. An NKT SuperK (Power SK PP485) supercontinuum white light laser served as excitation light source. For excitation and emission detection of specific fluorophores custom band-pass filters (excitation 470/40, 577/25 or 640/30 nm; emission 525/50, 632/60 or 690/50 nm) in combination with an Andor Neo sCMOS Camera. For image acquisition, Z-steps 3 μm were chosen. 3D reconstruction and analysis of ultramicroscopy stacks were performed by using the volume rendering software Voreen [39, 56].

Two-photon laser scanning microscopy

For ex vivo imaging of embryonic dermal lymphatic vessels and adult diaphragm tissue a LaVision TriM Scope II microscope (LaVision BioTec, Bielefeld, Germany) was used with a water dipping objective (CFI-Apo LWD 25XW, NA = 1.1, WD = 2.0 mm, Nikon). This system is equipped with a Chameleon Discovery ultrafast tuneable, which is used to pump an optical parametric oscillator (OPO that generates wavelengths greater than 1000 nm and a Chameleon XR Femtosecond Ti:Sapphire laser (Coherent, Santa Clara, USA) to generate wavelengths up to 850 nm. Either second harmonic generation signal (SHG) or Alexa Fluor^™ 647 were simultaneously excited at 1100 nm with tdTomato.

Supporting information

S1 Fig. Expression of the Vegfr3-tdTomato transgene in the developing retina and the liver.

MIPs of representative confocal tile-scans from immunostained wholemount preparations of the developing retina (A) and vibratome sections of the liver (B) of postnatal Vegfr3-tdTomato transgenic mice. Stained antigens are indicated above each panel. Yellow arrow heads in B indicate VEGFR-3 and RFP double positive sinusoids. PV = portal vein. Scale bars = 300 μm (A) and 100 μm (B).

(TIF)

Click here for additional data file.^{(4MB, tif)}

S2 Fig. FACS analysis of isolated cells from the lung of Vegfr3-tdTomato mice.

Representative FACS plots and gating scheme are shown. Isolated cells immunostained for the pan-endothelial cell marker CD31 and the common lymphatic surface marker PDPN were gated on FSC and SSC (A) to exclude cellular debris and doublets (B), and on staining with DAPI (C) to exclude dead cells. Different cell populations co-expressing CD31 and PDPN (D), were analysed for tdTomato positivity (E and F).

(TIF)

Click here for additional data file.^{(2MB, tif)}

S1 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the lung of a 5-day old mouse pup.

The explanted organ was fixed and wholemount immunostained with anti RFP antibodies. For tissue clearing the sample was dehydrated and delipidated by stepwise incubation in increasing concentrations of methanol followed by refractory index matching in BABB. Image stacks acquired by LSFM were digitally rendered using the open source visualization software package Voreen. Shown is a consecutive slice view throughout the sample, followed by volume reconstruction of the vessel bed, a 360 degree turn and a zoom in to reveal details of the LVs (red). The organ volume is outline by tissue autofluorescence (green).

(MP4)

Click here for additional data file.^{(11.3MB, mp4)}

S2 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the kidney of a 5-day old mouse pup.

(MP4)

Click here for additional data file.^{(7.8MB, mp4)}

S3 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the heart of a 5-day old mouse pup.

(MP4)

Click here for additional data file.^{(6.9MB, mp4)}

S1 Raw images

(PDF)

Click here for additional data file.^{(3.1MB, pdf)}

Acknowledgments

We are grateful to Dietmar Vestweber for his support and provision of valuable reagents. We thank Barbara Waschk, Ludmila Kremer and Nannette Kümpel-Rink for expert technical support.

Data Availability

All raw data files are are available from the figshare database (DOI: https://doi.org/10.6084/m9.figshare.14931708.v1).

Funding Statement

FK and ER are funded by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB1348/1 – 386797833 (https://gepris.dfg.de/gepris/projekt/386797833) and FK by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB1450/1 - 431460824 (https://gepris.dfg.de/gepris/projekt/431460824). FK and RH are funded by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB656/3 – 12467772 (https://gepris.dfg.de/gepris/projekt/12467772). NK is funded by CiM-IMPRS, the joint graduate school of the Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), University of Münster, Germany and the International Max Planck Research School - Molecular Biomedicine, Münster, Germany (https://gepris.dfg.de/gepris/projekt/194347757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1.Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349–62. Epub 2007/09/12. doi: 10.1084/jem.20062596 . [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Dougherty PJ, Davis MJ, Zawieja DC, Muthuchamy M. Calcium sensitivity and cooperativity of permeabilized rat mesenteric lymphatics. Am J Physiol Regul Integr Comp Physiol. 2008;294(5):R1524–32. Epub 2008/02/29. doi: 10.1152/ajpregu.00888.2007 . [DOI] [PubMed] [Google Scholar]
3.Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193(4):607–18. Epub 2011/05/18. doi: 10.1083/jcb.201012094 . [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Sabine A, Saygili Demir C, Petrova TV. Endothelial Cell Responses to Biomechanical Forces in Lymphatic Vessels. Antioxid Redox Signal. 2016;25(7):451–65. Epub 2016/04/22. doi: 10.1089/ars.2016.6685 . [DOI] [PubMed] [Google Scholar]
5.Moore JE Jr., Bertram CD. Lymphatic System Flows. Annu Rev Fluid Mech. 2018;50:459–82. Epub 2018/05/02. doi: 10.1146/annurev-fluid-122316-045259 . [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371–80. Epub 2011/11/09. doi: 10.1038/nm.2545 . [DOI] [PubMed] [Google Scholar]
7.Hägerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams RH, et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. Embo j. 2013;32(5):629–44. Epub 2013/01/10. doi: 10.1038/emboj.2012.340 . [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Yang Y, García-Verdugo JM, Soriano-Navarro M, Srinivasan RS, Scallan JP, Singh MK, et al. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood. 2012;120(11):2340–8. doi: 10.1182/blood-2012-05-428607 [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dubé KN, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 2015;522(7554):62–7. doi: 10.1038/nature14483 [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Stanczuk L, Martinez-Corral I, Ulvmar MH, Zhang Y, Laviña B, Fruttiger M, et al. cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels. Cell Reports. 2015;10(10):1708–21. doi: 10.1016/j.celrep.2015.02.026 [DOI] [PubMed] [Google Scholar]
11.Martinez-Corral I, Ulvmar MH, Stanczuk L, Tatin F, Kizhatil K, John SWM, et al. Nonvenous Origin of Dermal Lymphatic Vasculature. Circulation Research. 2015;116(10):1649–54. doi: 10.1161/CIRCRESAHA.116.306170 [DOI] [PubMed] [Google Scholar]
12.Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, et al. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol. 2008;28(15):4843–50. Epub 2008/06/04. doi: 10.1128/MCB.02214-07 . [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74–80. Epub 2003/11/25. doi: 10.1038/ni1013 . [DOI] [PubMed] [Google Scholar]
14.Karkkainen MJ, Jussila L, Ferrell RE, Finegold DN, Alitalo K. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol Med. 2001;7(1):18–22. Epub 2001/06/29. doi: 10.1016/s1471-4914(00)01864-5 . [DOI] [PubMed] [Google Scholar]
15.Kim KE, Sung HK, Koh GY. Lymphatic development in mouse small intestine. Dev Dyn. 2007;236(7):2020–5. Epub 2007/06/20. doi: 10.1002/dvdy.21200 . [DOI] [PubMed] [Google Scholar]
16.Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. Embo j. 2001;20(17):4762–73. Epub 2001/09/05. doi: 10.1093/emboj/20.17.4762 . [DOI] [PMC free article] [PubMed] [Google Scholar]
17.Nurmi H, Saharinen P, Zarkada G, Zheng W, Robciuc MR, Alitalo K. VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption. EMBO Mol Med. 2015;7(11):1418–25. Epub 2015/10/16. doi: 10.15252/emmm.201505731 . [DOI] [PMC free article] [PubMed] [Google Scholar]
18.Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454(7204):656–60. Epub 2008/07/03. doi: 10.1038/nature07083 . [DOI] [PubMed] [Google Scholar]
19.Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol. 2010;188(1):115–30. Epub 2010/01/13. doi: 10.1083/jcb.200903137 . [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Sciences. 1995;92(8):3566–70. doi: 10.1073/pnas.92.8.3566 [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3. Science. 1998;282(5390):946–9. doi: 10.1126/science.282.5390.946 [DOI] [PubMed] [Google Scholar]
22.Choi I, Chung HK, Ramu S, Lee HN, Kim KE, Lee S, et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood. 2011;117(1):362–5. Epub 2010/10/22. doi: 10.1182/blood-2010-07-298562 [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Jung E, Gardner D, Choi D, Park E, Jin Seong Y, Yang S, et al. Development and Characterization of A Novel Prox1-EGFP Lymphatic and Schlemm’s Canal Reporter Rat. Scientific Reports. 2017;7(1):5577. doi: 10.1038/s41598-017-06031-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Kang GJ, Ecoiffier T, Truong T, Yuen D, Li G, Lee N, et al. Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis. Scientific Reports. 2016;6(1):19459. doi: 10.1038/srep19459 [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Hägerling R, Pollmann C, Kremer L, Andresen V, Kiefer F. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochemical Society Transactions. 2011;39(6):1674–81. doi: 10.1042/BST20110722 [DOI] [PubMed] [Google Scholar]
26.Bianchi R, Teijeira A, Proulx ST, Christiansen AJ, Seidel CD, Rülicke T, et al. A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research. PLOS ONE. 2015;10(4):e0122976. doi: 10.1371/journal.pone.0122976 [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Hong M, Jung E, Yang S, Jung W, Seong YJ, Park E, et al. Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells. PLoS One. 2016;11(6):e0157126. Epub 2016/06/10. doi: 10.1371/journal.pone.0157126. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Truman LA, Bentley KL, Smith EC, Massaro SA, Gonzalez DG, Haberman AM, et al. ProxTom Lymphatic Vessel Reporter Mice Reveal Prox1 Expression in the Adrenal Medulla, Megakaryocytes, and Platelets. The American Journal of Pathology. 2012;180(4):1715–25. doi: 10.1016/j.ajpath.2011.12.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
29.Calvo CF, Fontaine RH, Soueid J, Tammela T, Makinen T, Alfaro-Cervello C, et al. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev. 2011;25(8):831–44. Epub 2011/04/19. doi: 10.1101/gad.615311 . [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Martínez-Corral I, Olmeda D, Diéguez-Hurtado R, Tammela T, Alitalo K, Ortega S. In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proceedings of the National Academy of Sciences. 2012;109(16):6223–8. doi: 10.1073/pnas.1115542109 [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature. 2017;546(7660):676–80. doi: 10.1038/nature22977 [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Watanabe C, Matsushita J, Azami T, Tsukiyama-Fujii S, Tsukiyama T, Mizuno S, et al. Generating Vegfr3 reporter transgenic mouse expressing membrane-tagged Venus for visualization of VEGFR3 expression in vascular and lymphatic endothelial cells. PLOS ONE. 2019;14(1):e0210060. doi: 10.1371/journal.pone.0210060 [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nature Biotechnology. 2004;22(12):1567–72. doi: 10.1038/nbt1037 [DOI] [PubMed] [Google Scholar]
34.Ding B-S, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468(7321):310–5. doi: 10.1038/nature09493 [DOI] [PMC free article] [PubMed] [Google Scholar]
35.Pollmann C, Hagerling R, Kiefer F. Visualization of lymphatic vessel development, growth, and function. Adv Anat Embryol Cell Biol. 2014;214:167–86. doi: 10.1007/978-3-7091-1646-3_13 [DOI] [PubMed] [Google Scholar]
36.Drobizhev M, Makarov NS, Tillo SE, Hughes TE, Rebane A. Two-photon absorption properties of fluorescent proteins. Nature Methods. 2011;8(5):393–9. doi: 10.1038/nmeth.1596 [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Kirschnick N, Drees D, Redder E, Erapaneedi R, Pereira da Graca A, Schäfers M, et al. Rapid methods for the evaluation of fluorescent reporters in tissue clearing and the segmentation of large vascular structures. iScience. 2021:102650. doi: 10.1016/j.isci.2021.102650 [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Hagerling R, Drees D, Scherzinger A, Dierkes C, Martin-Almedina S, Butz S, et al. VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformations. JCI Insight. 2017;2(16). Epub 2017/08/18. doi: 10.1172/jci.insight.93424. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Dierkes C, Scherzinger A, Kiefer F. Three-Dimensional Visualization of the Lymphatic Vasculature. Methods Mol Biol. 2018;1846:1–18. Epub 2018/09/23. doi: 10.1007/978-1-4939-8712-2_1 . [DOI] [PubMed] [Google Scholar]
40.Brakenhielm E, Alitalo K. Cardiac lymphatics in health and disease. Nat Rev Cardiol. 2019;16(1):56–68. Epub 2018/10/20. doi: 10.1038/s41569-018-0087-8 . [DOI] [PubMed] [Google Scholar]
41.Orlich M, Kiefer F. A qualitative comparison of ten tissue clearing techniques. Histol Histopathol. 2018;33(2):181–99. Epub 2017/05/13. doi: 10.14670/HH-11-903 . [DOI] [PubMed] [Google Scholar]
42.Connor AL, Kelley PM, Tempero RM. Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis. Laboratory Investigation. 2016;96(3):270–82. doi: 10.1038/labinvest.2015.147 [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Matsumoto K, Azami T, Otsu A, Takase H, Ishitobi H, Tanaka J, et al. Study of normal and pathological blood vessel morphogenesis in Flt1-tdsRed BAC Tg mice. genesis. 2012;50(7):561–71. doi: 10.1002/dvg.22031 [DOI] [PubMed] [Google Scholar]
44.Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, et al. Universal GFP reporter for the study of vascular development. genesis. 2000;28(2):75–81. [DOI] [PubMed] [Google Scholar]
45.Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. Journal of Cell Biology. 2009;185(4):657–71. doi: 10.1083/jcb.200811159 [DOI] [PMC free article] [PubMed] [Google Scholar]
46.Jackson DG. Leucocyte Trafficking via the Lymphatic Vasculature—Mechanisms and Consequences. Frontiers in Immunology. 2019;10(471). doi: 10.3389/fimmu.2019.00471 [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Sosa-Pineda B, Wigle JT, Oliver G. Hepatocyte migration during liver development requires Prox1. Nature Genetics. 2000;25(3):254–5. doi: 10.1038/76996 [DOI] [PubMed] [Google Scholar]
48.Risebro CA, Searles RG, Melville AAD, Ehler E, Jina N, Shah S, et al. Prox1 maintains muscle structure and growth in the developing heart. Development. 2009;136(3):495–505. doi: 10.1242/dev.030007 [DOI] [PMC free article] [PubMed] [Google Scholar]
49.Dyer MA, Livesey FJ, Cepko CL, Oliver G. Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nature Genetics. 2003;34(1):53–8. doi: 10.1038/ng1144 [DOI] [PubMed] [Google Scholar]
50.Quintanilla M, Montero-Montero L, Renart J, Martín-Villar E. Podoplanin in Inflammation and Cancer. International Journal of Molecular Sciences. 2019;20(3):707. doi: 10.3390/ijms20030707 [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Petrova TV, Bono P, Holnthoner W, Chesnes J, Pytowski B, Sihto H, et al. VEGFR-3 Expression Is Restricted to Blood and Lymphatic Vessels in Solid Tumors. Cancer Cell. 2008;13(6):554–6. doi: 10.1016/j.ccr.2008.04.022 [DOI] [PubMed] [Google Scholar]
52.Kirschnick N, Drees D, Redder E, Erapaneedi R, Pereira da Graca A, Schäfers M, et al. Rapid Methods for the Evaluation of Fluorescent Reporters in Tissue Clearing and the Segmentation of Large Vascular Structures. iScience. 2021:38. doi: 10.1016/j.isci.2021.102650 [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med. 2006;203(7):1671–7. Epub 2006/07/05. doi: 10.1084/jem.20060565 . [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Hägerling R, Hoppe E, Dierkes C, Stehling M, Makinen T, Butz S, et al. Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds. The EMBO Journal. 2018;37(22):e98271. doi: 10.15252/embj.201798271 [DOI] [PMC free article] [PubMed] [Google Scholar]
55.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Meyer-Spradow J, Ropinski T, Mensmann J, Hinrichs K. Voreen: A Rapid-Prototyping Environment for Ray-Casting-Based Volume Visualizations. IEEE Computer Graphics and Applications. 2009;29(6):6–13. doi: 10.1109/MCG.2009.130 [DOI] [PubMed] [Google Scholar]

PLoS One. doi: 10.1371/journal.pone.0249256.r001

Decision Letter 0

Stefan Liebner

8 Apr 2021

PONE-D-21-08111

Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

PLOS ONE

Dear Dr. Kiefer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers particular raise the minor points that in some images the tdTomato reporter does not perfectly match the staining with LYVE1 and/or VEGFR3. Both reviewers suggest to perform analysis of LECs by FACS for the reporter and the lymphatic markers mentioned above. Moreover, reporter expression in other cells and tissues, as well as in angiogenic sprouts in the retina that have been reported to express VEGFR3 should be mentioned and discussed. In general, the advantages and disadvantages of the presented reporter mouse models should be highlighted and discussed in more depth.

Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact.

Please submit your revised manuscript by May 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Stefan Liebner, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

5. Please amend your Methods section and Ethics Statement to provide details about methods of animal anesthesia and euthanasia.

6. Thank you for including your ethics statement: "All animal procedures were performed according to relevant laws and institutional guidelines, were approved by the state animal ethics committee and were conducted with permission (84-02.04.2016.A218) granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia.".

Please amend your current ethics statement to include the full name of the ethics committee that approved your specific study.

For additional information about PLOS ONE submissions requirements for ethics oversight of animal work, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-animal-research

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

7. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

8. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors describe here a novel BAC transgenic Vegfr3-tdTomato mouse line for studying the lymphatic vasculature. By using multiple imaging modalities (confocal, 2-photon, light sheet) they highlight the technical potential of the newly described line and its application for analysis of lymphatic vessel architecture in large tissue samples. The data are convincing, with excellent quality of imaging showing lymphatic vessel labelling in multiple tissues. The line will undoubtedly become a valuable resource in the field as it provides multiple benefits compared to existing lines: for example, a single transgene driven expression of tdTomato characterized by fast maturation and exceptional brightness as well as suitability for intravital / deep tissue imaging using 2-photon microscopy due to near infrared excitation. I have just a few suggestions for consideration:

Major comments:

1. It would be informative to show if the reporter recapitulates the endogenous expression of Vegfr3 in a subset of BECs, for example sinusoidal ECs (e.g. liver) or tip cells of angiogenic sprouts (e.g. developing retina).

2. In Fig 3, it seems that some VEGFR3+LYVE1+ LECs are not positive for tdTom (or anti-RFP staining in this case). This is particularly evident in Fig 3C but can also be seen in Fig 3A. Overall, RFP signal intensity seems to be heterogenous and not necessarily correlating with VEGFR3 staining intensity. Could the authors comment on this? Flow cytometric analysis of tdTom+ LECs could be useful.

Minor comments:

1. line 244: “… the epicardium but hardly invade into the myocardium are described for larger mammals.” I believe it is a typo and should be “… the epicardium but hardly invade into the myocardium as described for larger mammals.

Reviewer #2: Redder et al report generation of Vegfr3-tdTomato transgenic mice and demonstrate utility of such model for visualization of lymphatic vessels in different organs using a variety of imaging approaches, such as confocal, light sheet and two-photon microscopy. Overall, the results are clearly presented and the manuscript is well written. The model will be a useful addition to the arsenal of tools for characterization of lymphatic vessels, especially in adult animals and pathological conditions. I have only few comments as detailed below.

1. It seems that a proportion of LECs does not express the reporter (e.g. Figure 3 C), could the authors quantify the proportion of such tdTomato-negative LECs using FACS?

2. In addition to LECs, Vegfr3 expression has been reported in the tips of sprouting blood vessels in postnatal retina and tumors, in some fenestrated blood endothelial cells, immune cells and neural stem cells in subventricular zone of brain. Do the authors observe such pattern of expression in their model?

3. The authors should discuss in more detail advantages and disadvantages of their model in comparison to other existing lymphatic reporter strains. For example, expression of Prox1 in multiple non-endothelial cell types sometimes precludes use of Prox1- based reporters.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 20;16(9):e0249256. doi: 10.1371/journal.pone.0249256.r002

Author response to Decision Letter 0

8 Jul 2021

Detailed point by point response to the Reviewers' comments on the manuscript PONE-D-21-08111 by Redder et al. “Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities”:

Review Comments to the Author

Reviewer #1:

The authors describe here a novel BAC transgenic Vegfr3-tdTomato mouse line for studying the lymphatic vasculature. By using multiple imaging modalities (confocal, 2-photon, light sheet) they highlight the technical potential of the newly described line and its application for analysis of lymphatic vessel architecture in large tissue samples. The data are convincing, with excellent quality of imaging showing lymphatic vessel labelling in multiple tissues. The line will undoubtedly become a valuable resource in the field as it provides multiple benefits compared to existing lines: for example, a single transgene driven expression of tdTomato characterized by fast maturation and exceptional brightness as well as suitability for intravital / deep tissue imaging using 2-photon microscopy due to near infrared excitation. I have just a few suggestions for consideration:

We thank the Reviewer #1 for the positive feedback. Indeed, we believe our novel reporter line offers several advantages over already published reporter lines for the identification of lymphatic vessels and therefore will contribute to the future investigation of the lymphatic system.

Major comments:

We thank the Reviewer for the suggestion. To analyze Vegfr3-tdTomato expression in these tissues, we performed wholemount staining of the explanted retina and on vibratome sections of the liver of transgenic mice. These data are included in the manuscript and we now show that the transgene was not detectable on the VEGFR-3-expressing BECs at the sprouting retinal front and only weakly labeled liver sinusoidal endothelial cells. It is therefore an excellent marker for LECs with little interference by expression on BECs, i.e. the Vegfr3-tdTomato transgenic mouse line is a valuable tool to study specifically lymphatic vessels.

We thank reviewer #1 for raising this important issue. As suggested, we analyzed single cell preparations from lung by cytometry. Indeed, in a CD31pos, PodoplaninHigh gate that should only contain double positive bona fide LECs, still more than half of the cells did not score positive for tdTomato, based on the endogenous fluorescence of the marker protein. We presume that a fraction of the cells was genuinely not labelled because insufficient promotor activity, while some of the cells may have been missed due to insufficient sensitivity of the flow cytometer. Clearly the proportion of positive cells was higher after immune staining. We nevertheless emphasize that the reporter faithfully labels all detectable lymphatic vessels in various tissues, hence provides some beneficial lymph vessel specificity.

Minor comments:

We thank the reviewer for carefully proof-reading the manuscript, the mistake has been corrected.

Reviewer #2:

Redder et al report generation of Vegfr3-tdTomato transgenic mice and demonstrate utility of such model for visualization of lymphatic vessels in different organs using a variety of imaging approaches, such as confocal, light sheet and two-photon microscopy. Overall, the results are clearly presented and the manuscript is well written. The model will be a useful addition to the arsenal of tools for characterization of lymphatic vessels, especially in adult animals and pathological conditions. I have only few comments as detailed below.

1. It seems that a proportion of LECs does not express the reporter (e.g. Figure 3 C), could the authors quantify the proportion of such tdTomato-negative LECs using FACS?

Quantification by flow cytometry has been performed, please see our response to reviewer #1.

We have probed expression in the tips of sprouting retinal blood vessels and liver sinusoidal endothelium, these data have now been included in the manuscript and provide string evidence for a lymph vessel specific activation of the reporter gene.

We thank reviewer #2 for this suggestion. We have now discussed these aspects in detail in lines 325-338 and 343-355 of the discussion, which put our Vegfr3-tdTomato mouse in perspective to other published reporter lines, especially those based on Prox1 promoter expression.

Attachment

Submitted filename: Vegfr3-tdTomato_Response_to_Reviewers.docx

Click here for additional data file.^{(15.5KB, docx)}

PLoS One. doi: 10.1371/journal.pone.0249256.r003

Decision Letter 1

Stefan Liebner

6 Sep 2021

Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

PONE-D-21-08111R1

Dear Dr. Kiefer,

I apologize for the delayed response, but we’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Stefan Liebner, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

Reviewer #1: Yes

**********

6. Review Comments to the Author

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

PLoS One. doi: 10.1371/journal.pone.0249256.r004

Acceptance letter

Stefan Liebner

10 Sep 2021

PONE-D-21-08111R1

Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

Dear Dr. Kiefer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Stefan Liebner

Academic Editor

PLOS ONE

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Fig. Expression of the Vegfr3-tdTomato transgene in the developing retina and the liver.

(TIF)

Click here for additional data file.^{(4MB, tif)}

S2 Fig. FACS analysis of isolated cells from the lung of Vegfr3-tdTomato mice.

(TIF)

Click here for additional data file.^{(2MB, tif)}

S1 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the lung of a 5-day old mouse pup.

(MP4)

Click here for additional data file.^{(11.3MB, mp4)}

S2 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the kidney of a 5-day old mouse pup.

(MP4)

Click here for additional data file.^{(7.8MB, mp4)}

S3 Video. Volume imaging and 3D reconstruction of the lymphatic vessel system in the heart of a 5-day old mouse pup.

(MP4)

Click here for additional data file.^{(6.9MB, mp4)}

S1 Raw images

(PDF)

Click here for additional data file.^{(3.1MB, pdf)}

Attachment

Submitted filename: Vegfr3-tdTomato_Response_to_Reviewers.docx

Click here for additional data file.^{(15.5KB, docx)}

Data Availability Statement

All raw data files are are available from the figshare database (DOI: https://doi.org/10.6084/m9.figshare.14931708.v1).

[pone.0249256.ref001] 1.Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349–62. Epub 2007/09/12. doi: 10.1084/jem.20062596 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref002] 2.Dougherty PJ, Davis MJ, Zawieja DC, Muthuchamy M. Calcium sensitivity and cooperativity of permeabilized rat mesenteric lymphatics. Am J Physiol Regul Integr Comp Physiol. 2008;294(5):R1524–32. Epub 2008/02/29. doi: 10.1152/ajpregu.00888.2007 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref003] 3.Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193(4):607–18. Epub 2011/05/18. doi: 10.1083/jcb.201012094 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref004] 4.Sabine A, Saygili Demir C, Petrova TV. Endothelial Cell Responses to Biomechanical Forces in Lymphatic Vessels. Antioxid Redox Signal. 2016;25(7):451–65. Epub 2016/04/22. doi: 10.1089/ars.2016.6685 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref005] 5.Moore JE Jr., Bertram CD. Lymphatic System Flows. Annu Rev Fluid Mech. 2018;50:459–82. Epub 2018/05/02. doi: 10.1146/annurev-fluid-122316-045259 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref006] 6.Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371–80. Epub 2011/11/09. doi: 10.1038/nm.2545 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref007] 7.Hägerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams RH, et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. Embo j. 2013;32(5):629–44. Epub 2013/01/10. doi: 10.1038/emboj.2012.340 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref008] 8.Yang Y, García-Verdugo JM, Soriano-Navarro M, Srinivasan RS, Scallan JP, Singh MK, et al. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood. 2012;120(11):2340–8. doi: 10.1182/blood-2012-05-428607 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref009] 9.Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dubé KN, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 2015;522(7554):62–7. doi: 10.1038/nature14483 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref010] 10.Stanczuk L, Martinez-Corral I, Ulvmar MH, Zhang Y, Laviña B, Fruttiger M, et al. cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels. Cell Reports. 2015;10(10):1708–21. doi: 10.1016/j.celrep.2015.02.026 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref011] 11.Martinez-Corral I, Ulvmar MH, Stanczuk L, Tatin F, Kizhatil K, John SWM, et al. Nonvenous Origin of Dermal Lymphatic Vasculature. Circulation Research. 2015;116(10):1649–54. doi: 10.1161/CIRCRESAHA.116.306170 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref012] 12.Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, et al. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol. 2008;28(15):4843–50. Epub 2008/06/04. doi: 10.1128/MCB.02214-07 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref013] 13.Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74–80. Epub 2003/11/25. doi: 10.1038/ni1013 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref014] 14.Karkkainen MJ, Jussila L, Ferrell RE, Finegold DN, Alitalo K. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol Med. 2001;7(1):18–22. Epub 2001/06/29. doi: 10.1016/s1471-4914(00)01864-5 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref015] 15.Kim KE, Sung HK, Koh GY. Lymphatic development in mouse small intestine. Dev Dyn. 2007;236(7):2020–5. Epub 2007/06/20. doi: 10.1002/dvdy.21200 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref016] 16.Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. Embo j. 2001;20(17):4762–73. Epub 2001/09/05. doi: 10.1093/emboj/20.17.4762 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref017] 17.Nurmi H, Saharinen P, Zarkada G, Zheng W, Robciuc MR, Alitalo K. VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption. EMBO Mol Med. 2015;7(11):1418–25. Epub 2015/10/16. doi: 10.15252/emmm.201505731 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref018] 18.Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454(7204):656–60. Epub 2008/07/03. doi: 10.1038/nature07083 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref019] 19.Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol. 2010;188(1):115–30. Epub 2010/01/13. doi: 10.1083/jcb.200903137 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref020] 20.Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Sciences. 1995;92(8):3566–70. doi: 10.1073/pnas.92.8.3566 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref021] 21.Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3. Science. 1998;282(5390):946–9. doi: 10.1126/science.282.5390.946 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref022] 22.Choi I, Chung HK, Ramu S, Lee HN, Kim KE, Lee S, et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood. 2011;117(1):362–5. Epub 2010/10/22. doi: 10.1182/blood-2010-07-298562 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref023] 23.Jung E, Gardner D, Choi D, Park E, Jin Seong Y, Yang S, et al. Development and Characterization of A Novel Prox1-EGFP Lymphatic and Schlemm’s Canal Reporter Rat. Scientific Reports. 2017;7(1):5577. doi: 10.1038/s41598-017-06031-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref024] 24.Kang GJ, Ecoiffier T, Truong T, Yuen D, Li G, Lee N, et al. Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis. Scientific Reports. 2016;6(1):19459. doi: 10.1038/srep19459 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref025] 25.Hägerling R, Pollmann C, Kremer L, Andresen V, Kiefer F. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochemical Society Transactions. 2011;39(6):1674–81. doi: 10.1042/BST20110722 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref026] 26.Bianchi R, Teijeira A, Proulx ST, Christiansen AJ, Seidel CD, Rülicke T, et al. A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research. PLOS ONE. 2015;10(4):e0122976. doi: 10.1371/journal.pone.0122976 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref027] 27.Hong M, Jung E, Yang S, Jung W, Seong YJ, Park E, et al. Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells. PLoS One. 2016;11(6):e0157126. Epub 2016/06/10. doi: 10.1371/journal.pone.0157126. [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref028] 28.Truman LA, Bentley KL, Smith EC, Massaro SA, Gonzalez DG, Haberman AM, et al. ProxTom Lymphatic Vessel Reporter Mice Reveal Prox1 Expression in the Adrenal Medulla, Megakaryocytes, and Platelets. The American Journal of Pathology. 2012;180(4):1715–25. doi: 10.1016/j.ajpath.2011.12.026 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref029] 29.Calvo CF, Fontaine RH, Soueid J, Tammela T, Makinen T, Alfaro-Cervello C, et al. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev. 2011;25(8):831–44. Epub 2011/04/19. doi: 10.1101/gad.615311 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref030] 30.Martínez-Corral I, Olmeda D, Diéguez-Hurtado R, Tammela T, Alitalo K, Ortega S. In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proceedings of the National Academy of Sciences. 2012;109(16):6223–8. doi: 10.1073/pnas.1115542109 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref031] 31.Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature. 2017;546(7660):676–80. doi: 10.1038/nature22977 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref032] 32.Watanabe C, Matsushita J, Azami T, Tsukiyama-Fujii S, Tsukiyama T, Mizuno S, et al. Generating Vegfr3 reporter transgenic mouse expressing membrane-tagged Venus for visualization of VEGFR3 expression in vascular and lymphatic endothelial cells. PLOS ONE. 2019;14(1):e0210060. doi: 10.1371/journal.pone.0210060 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref033] 33.Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nature Biotechnology. 2004;22(12):1567–72. doi: 10.1038/nbt1037 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref034] 34.Ding B-S, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468(7321):310–5. doi: 10.1038/nature09493 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref035] 35.Pollmann C, Hagerling R, Kiefer F. Visualization of lymphatic vessel development, growth, and function. Adv Anat Embryol Cell Biol. 2014;214:167–86. doi: 10.1007/978-3-7091-1646-3_13 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref036] 36.Drobizhev M, Makarov NS, Tillo SE, Hughes TE, Rebane A. Two-photon absorption properties of fluorescent proteins. Nature Methods. 2011;8(5):393–9. doi: 10.1038/nmeth.1596 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref037] 37.Kirschnick N, Drees D, Redder E, Erapaneedi R, Pereira da Graca A, Schäfers M, et al. Rapid methods for the evaluation of fluorescent reporters in tissue clearing and the segmentation of large vascular structures. iScience. 2021:102650. doi: 10.1016/j.isci.2021.102650 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref038] 38.Hagerling R, Drees D, Scherzinger A, Dierkes C, Martin-Almedina S, Butz S, et al. VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformations. JCI Insight. 2017;2(16). Epub 2017/08/18. doi: 10.1172/jci.insight.93424. [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref039] 39.Dierkes C, Scherzinger A, Kiefer F. Three-Dimensional Visualization of the Lymphatic Vasculature. Methods Mol Biol. 2018;1846:1–18. Epub 2018/09/23. doi: 10.1007/978-1-4939-8712-2_1 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref040] 40.Brakenhielm E, Alitalo K. Cardiac lymphatics in health and disease. Nat Rev Cardiol. 2019;16(1):56–68. Epub 2018/10/20. doi: 10.1038/s41569-018-0087-8 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref041] 41.Orlich M, Kiefer F. A qualitative comparison of ten tissue clearing techniques. Histol Histopathol. 2018;33(2):181–99. Epub 2017/05/13. doi: 10.14670/HH-11-903 . [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref042] 42.Connor AL, Kelley PM, Tempero RM. Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis. Laboratory Investigation. 2016;96(3):270–82. doi: 10.1038/labinvest.2015.147 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref043] 43.Matsumoto K, Azami T, Otsu A, Takase H, Ishitobi H, Tanaka J, et al. Study of normal and pathological blood vessel morphogenesis in Flt1-tdsRed BAC Tg mice. genesis. 2012;50(7):561–71. doi: 10.1002/dvg.22031 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref044] 44.Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, et al. Universal GFP reporter for the study of vascular development. genesis. 2000;28(2):75–81. [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref045] 45.Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. Journal of Cell Biology. 2009;185(4):657–71. doi: 10.1083/jcb.200811159 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref046] 46.Jackson DG. Leucocyte Trafficking via the Lymphatic Vasculature—Mechanisms and Consequences. Frontiers in Immunology. 2019;10(471). doi: 10.3389/fimmu.2019.00471 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref047] 47.Sosa-Pineda B, Wigle JT, Oliver G. Hepatocyte migration during liver development requires Prox1. Nature Genetics. 2000;25(3):254–5. doi: 10.1038/76996 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref048] 48.Risebro CA, Searles RG, Melville AAD, Ehler E, Jina N, Shah S, et al. Prox1 maintains muscle structure and growth in the developing heart. Development. 2009;136(3):495–505. doi: 10.1242/dev.030007 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref049] 49.Dyer MA, Livesey FJ, Cepko CL, Oliver G. Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nature Genetics. 2003;34(1):53–8. doi: 10.1038/ng1144 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref050] 50.Quintanilla M, Montero-Montero L, Renart J, Martín-Villar E. Podoplanin in Inflammation and Cancer. International Journal of Molecular Sciences. 2019;20(3):707. doi: 10.3390/ijms20030707 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref051] 51.Petrova TV, Bono P, Holnthoner W, Chesnes J, Pytowski B, Sihto H, et al. VEGFR-3 Expression Is Restricted to Blood and Lymphatic Vessels in Solid Tumors. Cancer Cell. 2008;13(6):554–6. doi: 10.1016/j.ccr.2008.04.022 [DOI] [PubMed] [Google Scholar]

[pone.0249256.ref052] 52.Kirschnick N, Drees D, Redder E, Erapaneedi R, Pereira da Graca A, Schäfers M, et al. Rapid Methods for the Evaluation of Fluorescent Reporters in Tissue Clearing and the Segmentation of Large Vascular Structures. iScience. 2021:38. doi: 10.1016/j.isci.2021.102650 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref053] 53.Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med. 2006;203(7):1671–7. Epub 2006/07/05. doi: 10.1084/jem.20060565 . [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref054] 54.Hägerling R, Hoppe E, Dierkes C, Stehling M, Makinen T, Butz S, et al. Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds. The EMBO Journal. 2018;37(22):e98271. doi: 10.15252/embj.201798271 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref055] 55.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pone.0249256.ref056] 56.Meyer-Spradow J, Ropinski T, Mensmann J, Hinrichs K. Voreen: A Rapid-Prototyping Environment for Ray-Casting-Based Volume Visualizations. IEEE Computer Graphics and Applications. 2009;29(6):6–13. doi: 10.1109/MCG.2009.130 [DOI] [PubMed] [Google Scholar]

PERMALINK

Vegfr3-tdTomato, a reporter mouse for microscopic visualization of lymphatic vessel by multiple modalities

Esther Redder

Nils Kirschnick

Stefanie Bobe

René Hägerling

Nils Rouven Hansmeier

Friedemann Kiefer

Roles

Abstract

Introduction

Results

Generation of a Vegfr3-tdTomato transgenic mouse line

Fig 1. Generation of the Vegfr3-tdTomato reporter mouse.

The tdTomato fluorescence is associated with the lymphatic vessel network and co-localizes with VEGFR-3 protein expression

Fig 2. Characterization of the reporter expression in Vegfr3-tdTomato transgenic mice.

Fig 3. Co-localization of the transgene-derived Vegfr3-tdTomato signal with bona fide lymphatic vessel markers in the dermis of the ear and diaphragm.

Fig 4. Lymph vessel-specific expression of the Vegfr3-tdTomato transgene in the mesentery.

The fluorescent reporter tdTomato is expressed in both capillary and collecting lymphatic vessels of various tissues

The Vegfr3-tdTomato mouse is a tool for two-photon microscopy

Fig 5. 2-Photon laser scanning microscopy images of lymphatic vessels from transgenic Vegfr3-tdTomato reporter mice.

The Vegfr3-tdTomato reporter model is also suitable for optical clearing and 3-dimensional visualization of lymphatic vessel networks by light-sheet fluorescence microscopy

Fig 6. Light sheet microscopic visualization of the lymphatic vasculature in transgenic Vegfr3-tdTomato reporter mice after organic solvent-based tissue clearing.

Fig 7. Light sheet microscopy of CUBIC-cleared tissues visualized Vegfr3-tdTomato transgene expression in lymphatic vessels of the mouse lung and heart.

Discussion

Conclusion

Material and methods

Generation of a Vegfr3-tdTomato reporter mouse

Animal experiments

Antibodies

Isolation of murine lung cells for flow cytometric analysis

Isolation and culture of dermal endothelial cells

Wholemount staining of embryonic and adult tissues

Optical tissue clearing

Microscopy

Widefield fluorescence microscopy

Stereomicroscopy

Confocal laser scanning microscopy and image processing

Light sheet fluorescence microscopy and 3D-image processing

Two-photon laser scanning microscopy

Supporting information

Acknowledgments

Data Availability

Funding Statement

References

Decision Letter 0

Stefan Liebner

Roles

Author response to Decision Letter 0

Decision Letter 1

Stefan Liebner

Roles

Acceptance letter

Stefan Liebner

Roles

Associated Data

Supplementary Materials

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases